Quality is a sector in a standard business professional setting that is universally important and needed, so when that priority is transposed to the needs of an ophthalmology CRO, quality is at a premium. How important is quality to the ophthalmology CRO, and how can one tell that a company shares the ideal that quality is an immediate priority?
The industry of ophthalmology CROs on the whole operates with ideals of running a company that is FDA compliant and quality is controlled, an operation that is arguably essential in the pharmaceutical industry. 1 In addition, it is essential that the drugs associated with a study are safe and consistent from a performance standpoint. The formulations involved with a drug must also be consistent and predictable when administered to a patient. 1 In the field of ophthalmology, the formulations in question are consistently changing to become better and more effective. With that, requirements for quality control are pushed forward to cite and discuss the safety and efficacy of the drug.
Quality as a priority
Highlighting quality as a priority for project approach is common in the industry. Along the expanse of time associated with a sponsor's clinical trial, quality is at a supposed premium in regards to how important it is to a company to practice QA at every level. The lessons a sponsor and CRO alike will learn from what was successful and not successful in regards to a clinical trial will predominantly be associated with quality control and auditing.
Having metrics on a homepage or piece of capability media is known to speak volumes about a CRO. Real time evidence that shows what the company has done in their respected fields will communicate experience and pride in the corpus of work in which they have participated. Prospective sponsors need to see some semblance of a body of work in regards to the CRO they are checking out. If the CRO has a dedicated space on their web page highlighting their areas of expertise in the field, or even better a branded piece of literature to show clients first hand, this will provide a logical first step in the process of information requests.
When a project is entering the planning stage, a vast amount of time will be relegated to discussing timelines. The questions that a sponsor must ask themselves when approaching a CRO is how the company approaches timelines. Do they place a staunch priority on setting and achieving timelines, and in addition, do they have real time examples of meeting deadlines and furthering a project due to that success? Timelines are important for a CRO, inherently, so if a CRO has lessons learned and real time experience with setting timelines and achieving them that will only increase their marketability in the field.
1. Quality Control of Pharmaceuticals. NCBI. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1927659/
2. Pharmaceutical Quality Control Testing. Lucideon. https://www.lucideon.com/industries/healthcare/pharmaceutical/pharmaceutical-quality-control-testing